Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Raptor Pharmaceuticals
Raptor Pharmaceuticals
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Bidness, ETC
Fri, 08/19/16 - 11:50 am
Shire
Raptor Pharmaceuticals
M&A
Retrophin
Rare Diseases
Raptor Soars After Retrophin Said to Consider Bid for Drugmaker
Bloomberg
Thu, 08/18/16 - 09:27 am
Raptor Pharmaceuticals
Retrophin
Martin Shkreli
4 Key Biopharma Movers of the Past Week
24/7 Wall St
Sun, 04/10/16 - 02:04 pm
Relypsa
Valeant Pharmaceuticals
Celator Pharmaceuticals
Raptor Pharmaceuticals
U.S. drug developer Raptor Pharmaceuticals explores sale -sources
Yahoo/Reuters
Thu, 04/7/16 - 09:35 am
Raptor Pharmaceuticals
M&A
Top 6 Biotech Movers From The Past Week
24/7 Wall St
Sat, 09/19/15 - 03:36 pm
Aerie Pharma
Can-Fite BioPharma
Intra-Cellular Therapies
Raptor Pharmaceuticals
TRACON Pharmaceuticals
XenoPort
Raptor buys into cystic fibrosis with a $418M deal
Fierce Biotech
Fri, 08/21/15 - 11:01 am
Raptor Pharmaceuticals
cystic fibrosis
Quinsair
Tripex
Big Downside Ahead for Raptor?
24/7 Wall St
Tue, 07/7/15 - 11:34 am
Raptor Pharmaceuticals
procysbi
After hep C cure, companies target next big liver disease market
Yahoo/Reuters
Sun, 11/9/14 - 09:46 am
hepatitis B
hepatitis
nonalcoholic steatohepatitis
Gilead
Galmed Pharmaceuticals
Raptor Pharmaceuticals
Conatus Pharmaceuticals
Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial
Yahoo/Benzinga
Thu, 02/20/14 - 08:19 am
Raptor Pharmaceuticals
RP103
Huntington's disease
Insiders Are Selling Raptor Pharmaceuticals
Seeking Alpha
Sat, 09/21/13 - 10:35 am
Raptor Pharmaceuticals
Have These 4 Biotechs Peaked?
Motley Fool
Mon, 09/16/13 - 11:04 am
biotech
Alexion
Pharmacyclics
Aegerion
Raptor Pharmaceuticals
Raptor's Procysbi approved for rare disease in EU
PharmaTimes
Sat, 09/14/13 - 11:05 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Will You Adopt This Orphan Drug?
Motley Fool
Sat, 09/7/13 - 12:00 pm
nephropathic cystinosis
Raptor Pharmaceuticals
procysbi
Raptor Pharmaceutical Corporation: A Dose Of Reality For Investors
Seeking Alpha
Thu, 08/29/13 - 09:05 am
Raptor Pharmaceuticals
Raptor receives positive orphan drug opinion from EU committee
Yahoo/Fly on the Wall
Mon, 07/22/13 - 10:19 am
Raptor Pharmaceuticals
Europe
procysbi
5 Speculative Biotech Stocks With Catalysts Pending: Revisited
Seeking Alpha
Wed, 07/17/13 - 12:42 pm
NewLink Genetics
OncoSec Medical
Arqule
Raptor Pharmaceuticals
Zogenix
US Exclusivity for Raptor's Procysbi
Yahoo/Zacks
Wed, 06/26/13 - 10:37 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
orphan drugs
Raptor Pharma's Procysbi Launched in the US
Yahoo/Zacks
Sat, 06/22/13 - 10:14 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
Pharmabiz
Sun, 05/5/13 - 11:07 am
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Raptor's FDA Approval Is New Test For Orphan Drug Pricing
TheStreet.com
Wed, 05/1/13 - 09:09 am
FDA
Raptor Pharmaceuticals
orphan drugs
procysbi
nephropathic cystinosis
Pages
1
2
3
next ›
last »